Store

Since 1955, this landmark masterwork has been revered for its authoritative presentation of the entire state of scientific and clinical knowledge about multiple sclerosis. The state-of-the-art 4th Edition presents the most recent information on the genetics and epidemiology, clinical neurology, pathogenesis, and management of this common neurological disease. Amply illustrated and referenced and beautifully written, McAlpine's Multiple Sclerosis has been described as A standard reference for multiple sclerosis researchers, embryonic 'MS-ologists' and hard-pressed clinical neurologists alike (Brain, review of the last edition). Reviews the earliest clinical and pathological descriptions of multiple sclerosis. Offers a very strong section on pathogenesis. Includes more than 550 high-quality illustrations clarifying important scientific and clinical concepts. Uses a remarkably clear presentation to make complicated data as easy as possible to understand. Presents the most recent information on genetics and epidemiology, with an emphasis on clinical relevance. Covers all of the latest approaches to diagnosis and management. Offers new chapters on treatment of the acute relapse, treatment of symptoms, and disease-modifying treatments. Includes contributions from four new world-renowned authors to reflect more international perspectives. Features a new, more user-friendly page design for enhanced ease of reference. SECTION ONE: THE STORY OF MULTIPLE SCLEROSIS 1. The story of multiple sclerosis The evolving concept of multiple sclerosis Naming and classifying the disease: 1868-1983<@lУ×=q ¾Û€

Multiple sclerosis has rapidly changed over the last decade into a condition necessitating a multi-disciplinary approach to both its management and understanding. This book reflects all these advances including contributions from genetics, immunology and molecular biology. The many new drugs, both approved or in advanced stages of clinical trials, which give cause for optimism for the treatment of the disease, are described. This new comprehensive work has both editors and contributors that bring together basic science researchers and clinicians from Europe and the USA. A comprehensive reference on multiple sclerosis covering diagnosis, treatment and scientific background.Coverage of emergent drugs which are not in other books, eg Antegrin, as well as current frontline drugs.International group of contributors which includes leading researchers in the field from USA, Switzerland, France, UK and Germany.Based on cutting edge research but stresses the practical issues of diagnosis and treatment needed by neurologists.Comprehensive coverage of primary treatment of the disease process itself and symptomatic therapies, sexual and bladder dysfunction and rehabilitation.Section I: Multiple sclerosis: history and clinical manifestations: History of multiple sclerosis. Clinical features of multiple sclerosis. Unusual presentations and variants of ideopathic central nervous system demyelinating diseases. Paediatric multiple sclerosis. Diagnosis of multiple sclerosis. Neuroimaging in multiple sclerosis. Cerebrospinal fluid analysis in multiple sclerosis. Natural history of multiple sclerosis. Epidemiology of multiple sclerosis. Clinical neurophysiology of multiple sclerosis. Section II: Multiple sclerosis: pathophysiology and biology: Neuropathology of multiple@g4záG® ¾Û€

DIVPThis volume in the distinguishedBAdvances in Neurology/Bseries focuses on multiple sclerosis and related demyelinating diseases. An international group of experts examines recent developments in diagnosis, treatment, and other aspects of clinical management. The latest cutting-edge research on the causes and mechanisms of these diseases is also discussed./PPCoverage includes detailed discussions on new diagnostic methods and the role of neuroimaging in diagnosis. Chapters present evidence-based treatment protocols and review current clinical testing of new therapies./P/divDIVThis volume in the distinguished Advances in Neurology series focuses on multiple sclerosis and related demyelinating diseases. An international group of experts examines recent developments in diagnosis, treatment, and other aspects of clinical management. The latest cutting-edge research on the causes and mechanisms of these diseases is also discussed. Coverage includes detailed discussions on new diagnostic methods and the role of neuroimaging in diagnosis. Chapters present evidence-based treatment protocols and review current clinical testing of new therapies./divDIVolliMultiple Sclerosisbrol type = 'a'liNatural history:ol type = 'i'liThe London, Ontario databaseliThe Lyon database/olGenetic Aspects Pathology:ol type = 'i'liHeterogeneity of pathologyliGray vs. White matter disease-Proposed author: Bruce Trapp. 30 manuscript pages including tables and references; 5 photos/diagrams/olBiology of MS:brThis section will discuss the current knowledge regarding the function of oligodendrocytes, their derivision from precursor cells, their properties (mostly from in vitro studies) and the potential for regeneration. Additionally, some studies are examining the genes that govern their differentiation, growth and function, .ol type = 'i'liThe Biology of Oligodendrocytes-Proposed author: Jack Antel. 30 manuscript pages including tables and ref@qo33333 ¾Û€

T-Cell Autoimmunity and Multiple Sclerosis (Neuroscience Intelligence

br

Multiple Sclerosis (MS) is an enigmatic immune mediated disease of the central nervous system that affects about 350,000 individuals in the US, and many more around the world. The mechanism of this disease is largely unknown and there is no cure for it. However, there are several well-characterized experimental animal models that help us understand and speculate about potential mechanisms of pathology in this disease. Many of the experimental therapies designed for this disease rely on testing the drugs in animal models before using it in clinical trials. This book combines for the first time the different experimental models for MS (including immune-mediated and viral) under one roof, and highlights aspects that are different or shared among these experimental models. Ita (TM)s aim is to improve our understanding of this devastating disease and help us think about potential additional therapies for it.From the reviews:pA specialist book that aims to combine and present information about every existing animal model for multiple sclerosis. The target audience for this book includes neuroscientists, neurologists, immunologists, microbiologists, and neuropathologists. Clearly, some neuroradiologists a ] will also benefit from the information in this book. For the readers of AJNR, it is thought that a primary use of this book might be a reference for those collaborating with basic neuroscientists. a ] This will be a valuable resource for any scientists a ] . (American Journal of Neuroradiology, January, 2007)

Handbook of Multiple Sclerosis, Fourth Edition

Myelination and Demyelination: Implications for Multiple Sclerosis

Magnetic Resonance in Multiple Sclerosis

Nearly 500,000 Americans have been diagnosed with multiple sclerosis. This issue covers topics such as the epidimiology of multiple sclerosis, immunology, neuroimaging, neuropsychological functioning, the management of depression in multiple sclerosis, immunomodulatroy therapy, the management of spasticity and tremors, and pain rehabilitation.1.An Overview Of Physical Rehabilitation For Multiple Sclerosis Patients (Kraft and Brown)br2.Epidemiology and Etiology of Multiple Sclerosis (Kurtzke)br3.Immunology and Pathology of Multiple Sclerosis (Cui)br4.Diagnosing Multiple Sclerosis and Its Imitators (Bowen)br5.Neuroimaging of Multiple Sclerosis (Simon)br6.Neuropsychological Functioning in Multiple Sclerosis (Ehde and Pepping)br7.Diagnosis and Management of Depression in Multiple Sclerosis Ehde and Bombardier)br8.Pain in Multiple Sclerosis (Ehde and Jensen)br9.Health Promotion and Wellness (Bombardier and Wadhwani)br10.A Practical Approach to Immunomodulatory Therapy of Multiple Sclerosis (Burks)br11.Management of Spasticity (Haselkorn)br12.Variables Impacting Social Participation and Vocation Yorkston, Klasner and Johnson)br13.Helping Patients Make Vocational Decisions (Johnson and Fraser)

1.Clinical Features and Diagnosis of Multiple Sclerosis (Lublin) 2.Natural History of Multiple Sclerosis (Kantarci, Weinshenker) 3.Genetics of Multiple Sclerosis (Oksenberg, Hauser) 4.The Pathology of Multiple Sclerosis (Lucchinetti, Parisis, Bruck) 5.Neuroimaging in Multiple Sclerosis (Traboulsee) 6.Immunology of Multiple Sclerosis (Bar-Or) 7.Managing Systems of Multiple Sclerosis (Schapiro) 8.Glatiramer Acetate in the Treatment of Multiple Sclerosis (Miller) 9.Natalizumab and Other Monoclonal Antibodies (O'Connor) 10.Immunosuppresive Therapy for Multiple Sclerosis (Weiner) 11.Immunoablation Therapy as a Treatment for Multiple Sclerosis(Atkins, Freedman) 12.Interferons in Multiple Sclerosis (Kappos) 13.Gender Issues (Coyle) 14.Neuropathobiology of Multiple Sclerosis (Peterson, Trapp)

Multiple Sclerosis: Experimental And Clinical Aspects (annals Of The N

Treatment of Multiple Sclerosis: Trial Design, Results, and Future Per

This revised new edition provides a detailed account of neuropsychiatric disorders associated with multiple sclerosis.This fully updated and revised new edition provides a detailed account of the many neuropsychiatric disorders associated with Multiple Sclerosis. Extremely relevant to both the research and the clinical setting, it describes behavioral abnormalities, explores their causes and provides a detailed account of currently available treatments.This fully updated and revised new edition provides a detailed account of the many neuropsychiatric disorders associated with Multiple Sclerosis. Extremely relevant to both the research and the clinical setting, it describes behavioral abnormalities, explores their causes and provides a detailed account of currently available treatments.Multiple sclerosis is the most common cause of neurological disability in young and middle aged adults. This fully updated and revised new edition provides a detailed account of the many neuropsychiatric disorders associated with MS and is relevant to both the research and the clinical setting. Using the latest brain imaging findings and results from treatment trials, it will be valuable to all mental health professionals, neurologists, and others caring for those affected by MS.Foreword G. Comi; 1. Multiple sclerosis: diagnosis and definitions; 2. Depression: prevalence, symptoms, diagnosis and clinical correlates; 3. Depression: aetiology and treatment; 4. Multiple sclerosis, bipolar affective disorder and euphoria; 5. Multiple sclerosis and pseudobulbar affect; 6. Multiple sclerosis and psychosis; 7. Cognitive impairment in multiple sclerosis; 8. The natural history of cognitive change in multiple sclerosis; 9. Cognitive impairment in multiple sclerosis: detection, management and significance; 10. Neuroimaging correlates of cognitive dysfunction; 11. Multiple sclerosis, disease modifying treatment and behavioral change; 12. Multiple sclerosis: a subcortical, white matter dementia?F@V,ÌÌÌÌÍ ¾Û€

The Clinical Neuropsychiatry of Multiple Sclerosis

Coping With Multiple Sclerosis

A Colour Atlas of Multiple Sclerosis and Other Myelin Disorders

Multiple sclerosis is a chronic and often disabling disease of the nervous system, affecting about 1 million people worldwide. Even though it has been known for over a hundred years, no cause or cure has yet been discovered -- but now there is hope. New therapies have been shown to slow the disease progress in some patients, and the pace of discoveries about the cellular machinery of the brain and spinal cord has accelerated.pThis book presents a comprehensive overview of multiple sclerosis today, as researchers seek to understand its processes, develop therapies that will slow or halt the disease and perhaps repair damage, offer relief for specific symptoms, and improve the abilities of MS patients to function in their daily lives.pThe panel reviews existing knowledge and identifies key research questions, focusing on:br-- Research strategies that have the greatest potential to understand the biological mechanisms of recovery and to translate findings into specific strategies for therapy.br-- How people adapt to MS and the research needed to improve the lives of people with MS.br-- Management of disease symptoms (cognitive impairment, depression, spasticity, vision problems, and others).pThe committee also discusses ways to build and financially support the MS research enterprise, including a look at challenges inherent in designing clinical trails. This book will be important to MS researchers, research funders, health care advocates for MS research and treatment, and interested patients and their families.

The Encyclopedia Of Multiple Sclerosis (facts On File Library Of Healt

Handbook of Multiple Sclerosis (Neurological Disease and Therapy, Vol

Believed to affect around 7 of every 1,000 individuals in the United States, the neurological disease multiple sclerosis can damage nerve tissue, destroy muscle, cause blindness, and take away the ability to walk. As the awareness of MS has increased, the desire to find a cure has become an organized cause. Funds for research have increased significantly. This work provides an historical overview of MS and those who have lived with and died from it, as well as medical treatments prescribed throughout the known history of the disease. It includes a listing of autobiographies, biographies, novels, videos, studies and films that concern multiple sclerosis, as well as an appendix of treatments.Though there are suggestions of earlier cases, multiple sclerosis first came to notice in the early 1800s, interest then dissolved into case histories and tissue samples for a hundred years. Believed to affect around 7 of every 1,000 individuals in the United States, the neurological disease multiple sclerosis can damage nerve tissue, destroy muscles, cause blindness, and take away the ability to walk. As the awareness of MS has increased, the desire to find a cure has become an organized cause. Funds for research have increased significantly. This work provides an historical overview of MS and those who have lived with and died from it, as well as medical treatments prescribed throughout the known history of the disease. It includes a listing of autobiographies, biographies, novels, videos, studies and films that concern multiple sclerosis, as well as a list of attempted treatments.

Magnetic Resonance Imaging In Multiple Sclerosis: An Atlas Of Diagnosi

Multiple Sclerosis: Its Impact from Childhood to Old Age (Mpn 26)

Understanding Multiple Sclerosis

Multiple sclerosis (MS) is a devastating demyelinating disease with complex aetiology which defies simple molecular description. Molecular Biology of Multiple Sclerosis provides a compendium of information on the molecular aspects of the disease. It embraces contributions on the biology and pathology of the cells of the central nervous system as well as recent advances in our understanding of the relevant biochemistry, immunology, genetics and virology. With this enhanced knowledge the prospects for transplantation and repair of the damaged myelin as well as approaches to rational therapy are considered. Studies in MS embrace a wide spectrum of disciplines and this volume will be indispensible to neurologist, molecular biologists, biochemists, microbiologists, geneticists and immunologists with an interest in MS.Partial table of contents:Molecular Sclerosis—A Molecular Conundrum (W. Russell).Molecular Cell Biology of Oligodendrocytes (K. Rogers, et al.).Molecular Biology of the Glia: Components of Myelin—PLP and Minor Myelin Proteins (P. Montague & I. Griffiths).Molecular Biology of the Glia: Astrocytes (S. Lee & C. Brosnan).Molecular Biology of Microglia (M. Cuzner).The Blood-Brain Barrier (B. Engelhardt).B Cells and Autoimmunity (H. Link).Genetic Aspects of MS (A. Spurkland & F. Vartdal).Glycolipids of the CNS (M. Saito & R. Yu).Viruses and MS (W. Russell).Index.

Multiple Sclerosis Care Manual is a concise and easy to use reference source for all aspects of care in the management and understanding of Multiple Sclerosis (MS). It is useful for all health professionals invovled in the care of people with MS, including hospital doctors and Gps, therapists and social workers, as well as interested carers and people affected by the condition. It takes account of the latest scientific evidence and guidelines in the management of MS, and takes a practical and pragmatic approach to the evaluation of controversial aspects of MS care.brThe book is divided into five sections, beginning with background information on MS history. The second sectino concentrates on the diagnosis of MS, while the third deals with ongoing management of the condition. Part four provides practical advice on auditing and service evaluation, and finally, the book lists additional resources, websites, charities and other useful information.brEach aspect of MS is easy to access, with simple line diagrams and tables, as well as examples of investigations, including MR scans. The book offers handy, easy to use information for practical and scientific information about MS.brThe handbook has been written by a neurologist, physiotherapist and specialist nurse, all leaders in their field, who are all involved in both MS research and active service delievery to people affected by the disease.brProfessor John Zajicek trained in Cambridge and London and has spent more than 20 years researching MS and looking after people who have it. He is currently working in the Peninsula Medical School in Plymouth, and leads a large research team that conducts research into clinical trials for people with MS, with a particular focus on the uses of cannabis derived medicines, and research into the mechanisms of MS.brProfessor Zajicek is on the MS Guidelines Committee of the Association of British Neurologists, and has advised NICE on aspects of MS. Mrs. Bernadette Porter ha@G·=p£× ¾Û€

Multiple Sclerosis Research: Proceedings Of The International Multiple